APVO icon

Aptevo Therapeutics
APVO

6 hedge funds and large institutions have $22.8K invested in Aptevo Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$12.2K
2
+$3.25K
3
+$2.69K
4
TRCT
Tower Research Capital (TRC)
New York
+$2.52K
5
SS
SBI Securities
Japan
+$650

Top Sellers

1
-$93K
2
-$53K
3
-$19.5K
4
DP
Diadema Partners
New Jersey
-$17.5K
5
Morgan Stanley
Morgan Stanley
New York
-$16.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$12.2K
TRCT
2
Tower Research Capital (TRC)
New York
$3.78K
CS
3
Clear Street
New York
$3.25K
Bank of America
4
Bank of America
North Carolina
$2.69K
SS
5
SBI Securities
Japan
$813
BlackRock
6
BlackRock
New York
$28
Morgan Stanley
7
Morgan Stanley
New York
$4
Osaic Holdings
8
Osaic Holdings
Arizona
$1
VF
9
Virtu Financial
New York
–
HF
10
HRT Financial
New York
–
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
–
DP
12
Diadema Partners
New Jersey
–
UBS Group
13
UBS Group
Switzerland
–
CFFP
14
Center for Financial Planning
Michigan
–